Trial Site Detail

 

Drug:
Dasatinib (BMS-354825)
Trial:
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Institut Gustave Roussy

     
Villejuif , Val de Narne 94805
France

 

Principal Investigator:
Jean-Yves Blay
Contact:
33-1-42-114-316
Activation Status of this Site:
Closed
Notes about this Site:
Institut Gustave Roussy Website:
http://www.gustaveroussy.fr/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.